title: Antimicrobial-resistant bacteria in the community setting.
abstract: Over the past decade, antimicrobial resistance has emerged as a major public-health crisis. Common bacterial pathogens in the community such as Streptococcus pneumoniae have become progressively more resistant to traditional antibiotics. Salmonella strains are beginning to show resistance to crucial fluoroquinolone drugs. Community outbreaks caused by a resistant form of Staphylococcus aureus, known as community-associated meticillin (formerly methicillin)-resistant Staphylococcus aureus, have caused serious morbidity and even deaths in previously healthy children and adults. To decrease the spread of such antimicrobial-resistant pathogens in the community, a greater understanding of their means of emergence and survival is needed.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Columbia University, College of Physicians & Surgeons, 630 West 168th Street, New York, New York 10032, USA. eyf2002@columbia.edu
authors.forename: E Yoko
authors.initials: EY
authors.lastname: Furuya
authors.forename: Franklin D
authors.initials: FD
authors.lastname: Lowy
mesh_terms: D000328:Adult; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D002648:Child; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology*; D004197:Disease Reservoirs; D024881:Drug Resistance, Bacterial; D005516:Food Microbiology; D006801:Humans; D016106:Methicillin Resistance; D010403:Penicillin Resistance; D011634:Public Health; D012475:Salmonella / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects